North China Pharmaceutical Company Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 2,543.4 million compared to CNY 2,712.98 million a year ago. Revenue was CNY 2,543.4 million compared to CNY 2,712.98 million a year ago. Net income was CNY 13.68 million compared to net loss of CNY 57.2 million a year ago. Basic earnings per share from continuing operations was CNY 0.008 compared to basic loss per share from continuing operations of CNY 0.035 a year ago. Diluted earnings per share from continuing operations was CNY 0.008 compared to diluted loss per share from continuing operations of CNY 0.035 a year ago.